Nationwide Fund Advisors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,903
Closed -$127K 2994
2017
Q3
$127K Hold
6,903
﹤0.01% 2810
2017
Q2
$114K Buy
6,903
+2,635
+62% +$36.7K ﹤0.01% 2848
2017
Q1
$59K Sell
4,268
-574
-12% -$9.22K ﹤0.01% 2955
2016
Q4
$92K Hold
4,842
﹤0.01% 2899
2016
Q3
$107K Hold
4,842
﹤0.01% 2867
2016
Q2
$88K Buy
4,842
+1,304
+37% +$22.5K ﹤0.01% 2962
2016
Q1
$64K Hold
3,538
﹤0.01% 2941
2015
Q4
$60K Hold
3,538
﹤0.01% 2966
2015
Q3
$64K Hold
3,538
﹤0.01% 2993
2015
Q2
$92K Buy
3,538
+2,193
+163% +$55.4K ﹤0.01% 3035
2015
Q1
$29K Buy
+1,345
New +$29K ﹤0.01% 3159

Other funds holding ENTL

Nationwide Fund Advisors's ENTL Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 6,903 shares — an estimated $127K sold.

Nationwide Fund Advisors first reported a position in ENTL in Q1 2015 and held it in 11 quarters. The position peaked at $127K in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 6,903 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $127K.
  • Nationwide Fund Advisors first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
  • Nationwide Fund Advisors's Entellus Medical, Inc. Common Stock position peaked at $127K in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.